At times, one has to write just to record for the history. That, a country's regulator invites media for webinar on clinical trials and when a question is asked, the reply is this 👇
https://twitter.com/AnooBhu/status/1334759117932544001
"My request was to limit the question regarding understanding the processes involved. About the specifics of the things you are questioning, there are forums…there are weekly press conferences by department / ministry. This question can be asked there."
downtoearth.org.in/news/health/dr…
downtoearth.org.in/news/health/dr…
Other issues related to CTs which were asked but were not taken up due to 'paucity of time':
The composition of ethics committees of institutions where these trials are going on
The role Central Drugs Standard Control Organisation’s own subject expert committee
The composition of ethics committees of institutions where these trials are going on
The role Central Drugs Standard Control Organisation’s own subject expert committee
Study designs and protocols
Data provided to SEC for granting permission to proceed to progressive phases of trials
Criteria for pausing a trial in India
Whether the DCGI would put all the related data in the public domain
(So on and so forth)
Data provided to SEC for granting permission to proceed to progressive phases of trials
Criteria for pausing a trial in India
Whether the DCGI would put all the related data in the public domain
(So on and so forth)
• • •
Missing some Tweet in this thread? You can try to
force a refresh
